Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Lechleider

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Developmental Biology|January 11, 2002
Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusionR J Lechleider, J L Ryan, L Garrett, et al.
The EMBO Journal|March 4, 1999
Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-betaX Yang, J J Letterio, R J Lechleider, et al.
The Journal of Biological Chemistry|April 8, 1994
SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptidesR D Case, E Piccione, G Wolf, et al.
Biochemical and Biophysical Research Communications|May 18, 1999
Functional analysis of human Smad1: role of the amino-terminal domainR H Xu, R J Lechleider, H M Shih, et al.
Genes & Development|June 17, 1998
Smad2 transduces common signals from receptor serine-threonine and tyrosine kinasesM P de Caestecker, W T Parks, C J Frank, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 15, 2000
Selective loss of the transforming growth factor-beta apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cellsS Larisch-Bloch, D Danielpour, N S Roche, et al.
The Journal of Biological Chemistry|October 15, 1993
Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptorR J Lechleider, S Sugimoto, A M Bennett, et al.
Cell|August 9, 1996
The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptorsT Wang, B Y Li, P D Danielson, et al.
Cell|March 12, 1993
SH2 domains recognize specific phosphopeptide sequencesZ Songyang, S E Shoelson, M Chaudhuri, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 1998
Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivatorT Shioda, R J Lechleider, S L Dunwoodie, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Developmental Biology|January 11, 2002
Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusionR J Lechleider, J L Ryan, L Garrett, et al.
The EMBO Journal|March 4, 1999
Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-betaX Yang, J J Letterio, R J Lechleider, et al.
The Journal of Biological Chemistry|April 8, 1994
SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptidesR D Case, E Piccione, G Wolf, et al.
Biochemical and Biophysical Research Communications|May 18, 1999
Functional analysis of human Smad1: role of the amino-terminal domainR H Xu, R J Lechleider, H M Shih, et al.
Genes & Development|June 17, 1998
Smad2 transduces common signals from receptor serine-threonine and tyrosine kinasesM P de Caestecker, W T Parks, C J Frank, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 15, 2000
Selective loss of the transforming growth factor-beta apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cellsS Larisch-Bloch, D Danielpour, N S Roche, et al.
The Journal of Biological Chemistry|October 15, 1993
Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptorR J Lechleider, S Sugimoto, A M Bennett, et al.
Cell|August 9, 1996
The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptorsT Wang, B Y Li, P D Danielson, et al.
Cell|March 12, 1993
SH2 domains recognize specific phosphopeptide sequencesZ Songyang, S E Shoelson, M Chaudhuri, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 1998
Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivatorT Shioda, R J Lechleider, S L Dunwoodie, et al.
Pageof 3